07.06.26 -- Understanding FDA's Plausible Mechanism Framework For Genetic Medicines

FSP partnerships are transforming clinical operations and delivering not only efficiency and scalability, but also the innovation needed to accelerate development and improve patient outcomes.

Annex 1’s updated CCS framework calls for a holistic contamination strategy. Learn how manufacturers can apply it to non-sterile sites and legacy facilities using tailored risk-based approaches.

Multi-product ATMP facilities need integrated teams, flexible design, and strategic HVAC to ensure scalability, contamination control, cost efficiency, and reliable long-term performance.

Virtual process modeling is helping to cut production time, reduce solvent use, and improve sustainability. Learn how digital twins enable faster scale‑up decisions and more efficient manufacturing.

Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.